TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 36.00
0.00 (0.00%)
May 8, 2026, 11:54 AM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 952.51 million as of May 8, 2026. Its market cap has decreased by -31.43% in one year.
Market Cap
952.51M
Enterprise Value
151.75M
Revenue
273.61M
Ranking
n/a
PE Ratio
23.68
Stock Price
36.00
Market Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 952.51M, a decrease of -55.39%. That is a compound annual growth rate of -17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 952.51M | 1.41% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.13B |
| Holy Stone Healthcare | 1.11B |
| Level Biotechnology | 1.10B |
| LabTurbo Biotech | 1.06B |
| GeneReach Biotechnology | 1.06B |
| Lukas Biomedical | 1.06B |
| U-Neuron Biomedical | 1.04B |
| Taiwan Advance Bio-Pharmaceutical | 967.50M |